Mydecine Speaker Series: Part III-Drug Development
Mydecine Speaker Series III - Drug Development
Can Psychedelic Drug Design Improve Safety and Efficacy for Medicine?
Microdose invites you to join the Mydecine Speaker Series, dedicated to the exploration of the incredible findings around the current psychedelic research and what the path to mainstream acceptance looks like.
Featuring Dr. Denton Hoyer, Drug Discovery Consultant, Mydecine Innovations Group Inc.
Robert Roscow Chief Scientific Officer and Co-Founder Mydecine Innovations Group Inc.
Debra Borchardt Co-founder and CEO of the financial news website Green Market Report
Paul A. Frewen, Ph.D., C.Psych., Associate Professor